Literature DB >> 20668368

Two new cases of polysomy 13 in canine prostate cancer.

N Reimann-Berg1, S Willenbrock, H Murua Escobar, N Eberle, I Gerhauser, R Mischke, J Bullerdiek, I Nolte.   

Abstract

Besides man, the dog is the only known mammalian species that spontaneously develops carcinomas of the prostate with considerable frequency. For this reason, the dog is considered to be the only useful animal model for spontaneously occurring prostate malignancies in man. Cytogenetic investigations of human prostate cancers have revealed the frequent occurrence of trisomies 7, 8, and 17. Chromosome analyses of canine prostate carcinomas are rare. In this report we present 2 cases of canine prostate cancer showing a clonal polysomy 13 along with complex karyotype changes. Along with a previous report demonstrating polysomy 13 as the only karyotype deviation in a canine prostate cancer the present report supports the hypothesis that in canine prostate cancer, polysomy 13 is a recurrent cytogenetic aberration linked to the development of the disease. As human chromosomes (HSA) 8q and 4q and the canine chromosome (CFA) 13 share high homology, these results suggest that a conserved area on these chromosomes is involved in tumorigenesis in both species.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20668368     DOI: 10.1159/000317077

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  10 in total

1.  Establishment and Characterization of FusionRed Stable Transfected Canine Prostate Adenocarcinoma and Transitional Cell Carcinoma Cells.

Authors:  Suhayla Alnajjar; Ingo Nolte; Jan Torben Schille; Sina Sender; Nares Trakoolju; Simon Villa Perez; Dietmar Zechner; Brigitte Vollmar; Christian Junghanss; Hugo Murua Escobar
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

2.  Characterization and evaluation of a new oncolytic vaccinia virus strain LIVP6.1.1 for canine cancer therapy.

Authors:  Ivaylo Gentschev; Sandeep S Patil; Marion Adelfinger; Stephanie Weibel; Ulrike Geissinger; Alexa Frentzen; Nanhai G Chen; Yong A Yu; Qian Zhang; Gregory Ogilvie; Aladar A Szalay
Journal:  Bioengineered       Date:  2012-10-23       Impact factor: 3.269

Review 3.  Domestic dogs and cancer research: a breed-based genomics approach.

Authors:  Brian W Davis; Elaine A Ostrander
Journal:  ILAR J       Date:  2014

4.  Characterization of six canine prostate adenocarcinoma and three transitional cell carcinoma cell lines derived from primary tumor tissues as well as metastasis.

Authors:  Eva-Maria Packeiser; Marion Hewicker-Trautwein; Heike Thiemeyer; Annika Mohr; Johannes Junginger; Jan Torben Schille; Hugo Murua Escobar; Ingo Nolte
Journal:  PLoS One       Date:  2020-03-13       Impact factor: 3.240

5.  Isoquinolinamine FX-9 Exhibits Anti-Mitotic Activity in Human and Canine Prostate Carcinoma Cell Lines.

Authors:  Jan Torben Schille; Ingo Nolte; Eva-Maria Packeiser; Laura Wiesner; Jens Ingo Hein; Franziska Weiner; Xiao-Feng Wu; Matthias Beller; Christian Junghanss; Hugo Murua Escobar
Journal:  Int J Mol Sci       Date:  2019-11-07       Impact factor: 5.923

6.  PDA Indolylmaleimides Induce Anti-Tumor Effects in Prostate Carcinoma Cell Lines Through Mitotic Death.

Authors:  Jan Torben Schille; Ingo Nolte; Julia Beck; Daria Jilani; Catrin Roolf; Anahit Pews-Davtyan; Arndt Rolfs; Larissa Henze; Matthias Beller; Bertram Brenig; Christian Junghanss; Ekkehard Schütz; Hugo Murua Escobar
Journal:  Front Vet Sci       Date:  2021-01-20

7.  Ablation of Red Stable Transfected Claudin Expressing Canine Prostate Adenocarcinoma and Transitional Cell Carcinoma Cell Lines by C-CPE Gold-Nanoparticle-Mediated Laser Intervention.

Authors:  Suhayla Alnajjar; Ingo Nolte; Annegret Becker; Jan Torben Schille; Nares Trakooljul; Marcus Frank; Anaclet Ngezahayo; Hugo Murua Escobar
Journal:  Int J Mol Sci       Date:  2021-11-13       Impact factor: 5.923

8.  Virotherapy of canine tumors with oncolytic vaccinia virus GLV-1h109 expressing an anti-VEGF single-chain antibody.

Authors:  Sandeep S Patil; Ivaylo Gentschev; Marion Adelfinger; Ulrike Donat; Michael Hess; Stephanie Weibel; Ingo Nolte; Alexa Frentzen; Aladar A Szalay
Journal:  PLoS One       Date:  2012-10-16       Impact factor: 3.240

9.  Generation and characterisation of a canine EGFP-HMGA2 prostate cancer in vitro model.

Authors:  Saskia Willenbrock; Siegfried Wagner; Nicola Reimann-Berg; Mohammed Moulay; Marion Hewicker-Trautwein; Ingo Nolte; Hugo Murua Escobar
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

Review 10.  Clinical Cytogenetics of the Dog: A Review.

Authors:  Izabela Szczerbal; Marek Switonski
Journal:  Animals (Basel)       Date:  2021-03-27       Impact factor: 2.752

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.